The global anti-snoring devices market is expected to grow from $1.81 billion in 2025 to $3.36 billion by 2033, with an 8.04% CAGR. Growth drivers include rising obesity rates, increased awareness of health risks associated with snoring, technological innovations, and improved e-commerce accessibility. Major players like Philips, ResMed, and SomnoMed are leading the market with advanced solutions.

ResMed reported strong Q2 FY2026 results with adjusted earnings of $2.81 beating consensus of $2.72, and sales of $1.42 billion up 11% YoY. The company received FDA clearance for its AI-enabled Smart Comfort device and expects high single-digit revenue growth with double-digit EPS growth. Most analysts maintain positive ratings despite competition concerns, though stock declined 2.33% on the day.

The global mechanical ventilators market is projected to grow from USD 4.04 billion in 2025 to USD 6.91 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by rising respiratory disease prevalence, expanding ICU infrastructure, and technological advancements including AI-enabled and portable ventilators. However, high device costs and limited healthcare funding remain significant market constraints.

The global sleep apnea devices market is projected to grow from USD 9.5 billion in 2024 to USD 15.8 billion by 2032, with a CAGR of approximately 6%. Growth is driven by rising OSA prevalence, technological advancements, increased awareness, and expanding healthcare infrastructure. North America leads the market with over 45% share, while Asia-Pacific emerges as a major growth driver. Key players include Philips, ResMed, and Fisher & Paykel Healthcare.

BVI announced the appointment of Jim Hollingshead as President & CEO, succeeding Shervin Korangy. Hollingshead brings over 20 years of medical device experience from leadership roles at Insulet and ResMed. BVI has expanded its ophthalmic portfolio with FDA approvals for premium IOLs and new surgical platforms, positioning itself as a challenger in the eye surgery market.

The global sleep tech devices market is expected to grow from USD 17 billion in 2024 to USD 44 billion by 2032, driven by rising sleep disorder prevalence, increased awareness, and technological advancements. Wearables dominate with 69.69% revenue share, while North America leads regional growth. Key players include Philips, ResMed, Apple, Garmin, and Eight Sleep.

Nyxoah secured $77 million in financing through a private placement, registered direct offering, and convertible bond to support U.S. commercialization of its Genio system for treating Obstructive Sleep Apnea (OSA).

The Saudi Arabia Sleep Apnea Devices Market is projected to grow from $4.35 billion in 2024 to $5.94 billion by 2030, driven by increasing awareness of sleep disorders and demand for diagnostic and therapeutic technologies.

The global sleep apnea devices market is projected to grow from $7.08 billion in 2024 to $14.59 billion by 2031, with a 10.42% CAGR, driven by rising sleep disorder prevalence, technological advancements, and improved diagnostic capabilities.

The global actigraphy devices market is expected to grow at a CAGR of 6.4% from 2025 to 2034, driven by the rising prevalence of sleep disorders, advancements in wearable technology, and increased awareness of sleep health.

ResMed reported strong Q3 results with double-digit EPS growth and a tariff exemption, leading analysts to boost their price forecasts for the company.

Resmed Inc. reported strong financial results for the third quarter of fiscal year 2025, with 9% constant currency revenue growth, 140 basis points improvement in non-GAAP gross margin, and double-digit EPS growth. The company's sleep and breathing health products and software solutions continue to see solid customer demand.